News-Detailansicht

Icon, Center Template, Diabetes, Featured Publication

Featured Publication, Diabetes, ITS,

New Study Reveals Key to How Pancreatic Insulin-Producing Beta Cells Are Formed

A research team led by Prof. Henrik Semb, Director of the Institute of Translational Stem Cell Research at Helmholtz Munich, has gained new insights into how immature pancreatic cells decide whether to become insulin-producing beta cells or…

Semb Lab Behind the Scenes

Diabetes, ITS, IDR,

Handcrafted Langerhans Islets: New Hope for Type 1 Diabetes Patients?

Our organs do a remarkable job day in and day out, without ourselves even having to think about it. Our body has its own ventilation system, a clearance system for toxins, and a system to balance energy homeostasis. But what if one of these systems…

Awards & Grants, ITS,

EU-Project ISLET: Helmholtz Munich takes over coordination

The EU-funded ISLET project brings together leading experts in the field of stem cell research to discover a new advanced cell therapy in type 1 diabetes. The aim is to free patients from the daily use of an insulin pump by replacing the damaged…

csm_INS_Red_PDX1_White_DAPI_Blue_1__a5905e7ee4

New Research Findings, ITS,

Trigger in MODY3 diabetes: Insulin hypersecretion precedes pancreatic β cell failure

In order to treat patients with diabetes in the best possible way it is necessary to understand the disease mechanism. MODY type 3 (MODY3) is a monogenic hereditary form of diabetes, that is caused by a genetic defect in the HNF1A gene. The result is…